SK Chemicals conducts Phase 3 clinical trial of cell culture influenza vaccine

SK Chemicals said Tuesday that it has carried out Phase 3 clinical tests for its influenza cell culture vaccine using animal cell after it gained the green light from the Ministry of Food and Drug Safety.

According to the company, the clinical trial will be conducted for adults and children in local university hospitals, including Korea Kuro Hospital, for nine months, in an effort to evaluat...